ISTO Technologies Acquired by Private Equity Firm

The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed. ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us